Performance and Impact on Antibiotic Prescriptions of a Multiplex PCR in a Real-Life Cohort of Critically Ill Patients with Suspected Ventilated Pneumonia: A Retrospective Monocentric Observational Study

Pulmonary multiplex polymerase chain reaction (m-PCR) allows rapid pathogen detection. We aimed to assess its impact on initial antibiotic prescriptions in ventilated patients with suspected pneumonia. Between November 2020 and March 2022,ventilated patients with suspected pneumonia hospitalized in...

Full description

Saved in:
Bibliographic Details
Main Authors: Emma Chambe (Author), Perrine Bortolotti (Author), Rémy Diesnis (Author), Caroline Laurans (Author), Rozenn Héquette-Ruz (Author), Sophie Panaget (Author), Patrick Herbecq (Author), Anne Vachée (Author), Agnès Meybeck (Author)
Format: Book
Published: MDPI AG, 2023-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_668cca9ab49b45f6b6d84c8f18eb373d
042 |a dc 
100 1 0 |a Emma Chambe  |e author 
700 1 0 |a Perrine Bortolotti  |e author 
700 1 0 |a Rémy Diesnis  |e author 
700 1 0 |a Caroline Laurans  |e author 
700 1 0 |a Rozenn Héquette-Ruz  |e author 
700 1 0 |a Sophie Panaget  |e author 
700 1 0 |a Patrick Herbecq  |e author 
700 1 0 |a Anne Vachée  |e author 
700 1 0 |a Agnès Meybeck  |e author 
245 0 0 |a Performance and Impact on Antibiotic Prescriptions of a Multiplex PCR in a Real-Life Cohort of Critically Ill Patients with Suspected Ventilated Pneumonia: A Retrospective Monocentric Observational Study 
260 |b MDPI AG,   |c 2023-11-01T00:00:00Z. 
500 |a 10.3390/antibiotics12121646 
500 |a 2079-6382 
520 |a Pulmonary multiplex polymerase chain reaction (m-PCR) allows rapid pathogen detection. We aimed to assess its impact on initial antibiotic prescriptions in ventilated patients with suspected pneumonia. Between November 2020 and March 2022,ventilated patients with suspected pneumonia hospitalized in our ICU who benefited from respiratory sampling simultaneously tested using conventional microbiological methods and m-PCR were included. The proportion of appropriate changes in the initial antibiotic therapy following m-PCR results was assessed. We analyzed 104 clinical samples. Of the 47 negative m-PCR results, 16 (34%) led to an appropriate antibiotic strategy: 8 cessationsand 8 lack of initiation. Of the 57 positive m-PCR results, 51 (89%) resulted in an appropriate antibiotic strategy: 33 initiations, 2 optimizations, and 9 de-escalations. In the multivariate analysis, a positive m-PCR was associated with an appropriate antibiotic change (OR: 96.60; IC95% [9.72; 960.20], <i>p</i> < 0.001). A higher SAPS II score was negatively associated with an appropriate antibiotic change (OR: 0.96; IC95% [0.931; 0.997], <i>p</i> = 0.034). In our cohort, a positive m-PCR allowed for early initiation or adjustment of antibiotic therapy in almost 90% of cases. A negative m-PCR spared antibiotic use in onethird of cases. The impact of m-PCR results was reduced in the most severe patients. 
546 |a EN 
690 |a pneumonia 
690 |a multiplex PCR 
690 |a COVID-19 
690 |a antibiotic use 
690 |a intensive care 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Antibiotics, Vol 12, Iss 12, p 1646 (2023) 
787 0 |n https://www.mdpi.com/2079-6382/12/12/1646 
787 0 |n https://doaj.org/toc/2079-6382 
856 4 1 |u https://doaj.org/article/668cca9ab49b45f6b6d84c8f18eb373d  |z Connect to this object online.